Investec Asset Management »

Royalty Pharma shares owned by Investec Asset Management

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Investec Asset Management from 13F filings

Historical chart of Investec Asset Management investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Investec Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Investec Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $535k 9.5k 56.07

More positions owned by Investec Asset Management

Alphabet Common Stock (GOOGL)
NVIDIA Corp Common Stock (NVDA)
Visa Common Stock (V)
Microsoft Corp Common Stock (MSFT)
Johnson & Johnson Common Stock (JNJ)
Apple Common Stock (AAPL)
Philip Morris International Common Stock (PM)
Booking Holdings Common Stock (BKNG)
Amazon.com Common Stock (AMZN)
Edwards Lifesciences Corp Common Stock (EW)
Broadcom Common Stock (AVGO)
NetEase Adr (NTES)
Autodesk Common Stock (ADSK)
Taiwan Semiconductor Manufacturing Adr (TSM)
Eli Lilly & Co Common Stock (LLY)

View all positions for Investec Asset Management

Top funds holding Royalty Pharma

Morgan Stanley
Capital Research and Management Company - Division 3
BlackRock
FMR
State Street Corporation
Swedbank AB
Baillie Gifford & Co
Geode Capital Management
Capital World Investors
Caledonia
Norges Bank Investment Management
Vanguard Capital Management
Northern Trust
Royal London Asset Management
AQR Capital Management

View all funds holding Royalty Pharma